Evidence map›Paper›PMID 35472594›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2022

Impact of cannabis knowledge and attitudes on real-world practice.

Joanna S Zeiger, William S Silvers, David R Naimi, Isabel J Skypala, Anne K Ellis, Lori Connors, Samira Jeimy, Ajay P Nayak, Jonathan A Bernstein, Robert S Zeiger and 1 more

Open access · greenAbstract read
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. A review of cannabis allergy in the early days of legalization.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023
    Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 3 countries.

Joanna S ZeigerCanna Research Foundation, Boulder, Colorado. Electronic address: joanna@cannaresearchfoundation.org.
William S SilversCanna Research Foundation, Boulder, Colorado; University of Colorado School of Medicine, Denver, Colorado.
David R NaimiNaval Hospital Camp Pendleton, Oceanside, California.
Isabel J SkypalaRoyal Brompton & Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Anne K EllisDepartment of Medicine, Queen's University, Kingston, Ontario, Canada.
Lori ConnorsDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Samira JeimyDivision of Clinical Immunology and Allergy, Department of Medicine, Western University, London, Ontario, Canada.
Ajay P NayakThomas Jefferson University, Philadelphia, Pennsylvania.
Jonathan A BernsteinUniversity of Cincinnati College of Medicine, Bernstein Allergy Group, Cincinnati, Ohio.
Robert S ZeigerCanna Research Foundation, Boulder, Colorado; Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
International Allergist Canna KAP Consortium
Bernstein Clinical Research Center · USDalhousie University · CAGuy's and St Thomas' NHS Foundation Trust · GBJonah’s Just Begun · USKaiser Permanente · USNaval Medical Center San Diego · USQueen's University · CAThomas Jefferson University · USUniversity of Colorado Boulder · USWestern University · CA

Funding

Allergic sensitization to Cannabis: Innovative diagnostic approachesR21AI140411 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI NAYAK, AJAY · 2019 to 2020
$429k
NIAID NIH HHS R21 AI140411
6 · The paper itself

Abstract

backgroundIncreased cannabis consumption worldwide challenges allergists because of an upsurge in cannabis allergy and need to discuss cannabis with patients.

objectiveTo determine the knowledge, attitudes, and practices regarding cannabis among allergists and their approach to recognizing and diagnosing suspected cannabis allergy.

methodsThe International Allergist Canna Knowledge, Attitudes, and Practices Survey was completed by members from 3 International Allergy Societies. Survey questions included the following: 13 on cannabis attitudes, 7 on cannabis knowledge, and 4 on real-world allergy practices. Knowledge level was dichotomized and Statistical Package for the Social Sciences TwoStep Cluster Analysis grouped participants by attitudes. Multivariate analysis determined the relationship of knowledge and attitude to practice delivery.

resultsOf 570 eligible surveys started, 445 (78.1%) were completed. Participants were 49.7% of female sex, 65.9% aged 24 to 56 years, approximately 70% in practice for more than or equal to 10 years, and 29.2% practicing in an area where cannabis use is illegal. Of the respondents, 43.1% reported consulting on patients with suspected cannabis allergy and 54.7% had undertaken skin prick testing, in vitro cannabis testing, or both. Statistically significant differences were found between the 3 societies for most variables analyzed. Analysis of attitudes revealed 3 clusters named Traditional, Progressive, and Unsure. Those with more progressive attitudes toward cannabis and who had more knowledge were more comfortable speaking to patients about cannabis and more often asked patients on how often and how they used cannabis (all P < .001).

conclusionVarying knowledge and attitudes toward cannabis affecting comfort communicating with patients about cannabis were found in members of 3 allergy societies supporting the need for more cannabis research and education.

Indexed as

CannabisHypersensitivityFemaleHealth Knowledge, Attitudes, PracticeHumansKnowledgeSurveys and Questionnaires

Identifiers

PMID35472594
PMCPMC9869714
OpenAlexW4224320271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.